0000000000447527

AUTHOR

Nuria Cruz

showing 2 related works from this author

Treatment nonadherence and neurocognitive impairment in bipolar disorder.

2009

OBJECTIVE: Little is known regarding the relationship between treatment adherence and residual cognitive dysfunction in euthymic bipolar disorder patients. This study aimed to investigate whether poor treatment adherence is associated with cognitive impairment in euthymic bipolar patients and whether other factors may be associated with both adherence and cognitive functioning. METHOD: Euthymic DSM-IV bipolar I or II disorder patients (N = 103: 61 with high levels of treatment adherence and 42 with poor treatment adherence) were assessed using a neuropsychological battery targeting attention, psychomotor speed, verbal memory, and executive functions and compared with 35 healthy controls of …

AdultMalemedicine.medical_specialtyBipolar DisorderComorbidityNeuropsychological TestsYoung Mania Rating ScaleVerbal learningSeverity of Illness IndexMemorymedicineHumansBipolar disorderPsychiatryPsychiatric Status Rating ScalesCognitive disorderHamilton Rating Scale for DepressionVerbal Learningmedicine.diseaseExecutive functionsDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthPatient ComplianceFemaleVerbal memoryPsychologyCognition DisordersLithium ChlorideNeurocognitivePsychomotor PerformanceClinical psychologyThe Journal of clinical psychiatry
researchProduct

Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.

2011

Abstract Background Different factors may influence cognitive functioning in bipolar disorder such as the effect of subsyndromal symptoms, the history of psychotic symptomatology or substance abuse, negative symptomatology, chronicity, sleep disturbances, and hormonal factors. The effect of pharmacologic treatment on cognition is still uncertain because of an insufficient number of studies examining this issue. Objective The aims of this study were to compare neuropsychologic performance of treated bipolar patients with that of controls, including unmedicated patients and healthy subjects, as well as to evaluate possible neurocognitive differences among 3 different atypical antipsychotics. …

OlanzapineAdultMalemedicine.medical_specialtyDibenzothiazepinesBipolar DisorderAdolescentlcsh:RC435-571medicine.drug_classmedicine.medical_treatmentEmotionsAtypical antipsychoticNeuropsychological TestsYoung Mania Rating ScaleBenzodiazepinesExecutive FunctionQuetiapine FumarateYoung AdultCognitionMemorylcsh:PsychiatrymedicineHumansAttentionBipolar disorderPsychiatryAntipsychoticPsychiatric Status Rating ScalesRisperidoneCalifornia Verbal Learning TestMiddle Agedmedicine.diseaseRisperidonePsychiatry and Mental healthClinical PsychologyOlanzapineCase-Control StudiesQuetiapineFemalePsychologymedicine.drugClinical psychologyAntipsychotic AgentsComprehensive psychiatry
researchProduct